Davis KL, Meyers J, Zhao Z, McCollam PL, Murakami M. High-risk atherosclerotic cardiovascular disease in a real-world employed Japanese population: prevalence, cardiovascular event rates, and costs. J Atheroscler Thromb. 2015 Dec 1;22(12):1287-304. doi: 10.5551/jat.28852
Davis KL, Lin HM, Hui AM, Zhang S, Kaye JA. Assessment of real-world treatment patterns and outcomes in relapsed or refractory multiple myeloma: evidence from a brief multi-country survey of European physicians. Poster presented at the International Society for Pharmacoeconomics and Outcomes Research 18th Annual European Congress; November 2015. Milan, Italy.
Goyal RK, Davis KL, Cote I, Mounedji N, Kaye JA. Health care resource use and costs among polycythemia vera patients in the United States: results from an observational cohort study. Poster presented at the 2015 ISPOR 18th Annual European Congress; November 2015. Milan, Italy.
Davis KL, Cote I, Kaye JA, Mendelson E, Gao H, Perez Ronco J. Real-world assessment of clinical outcomes in patients with lower-risk myelofibrosis receiving treatment with ruxolitinib. Adv Hematol. 2015 Oct;2015(2015):848473. doi: 10.1155/2015/848473
Meyers J, Grebla R, Ajmera M, Davis K, Pawaskar M. Comorbidity burden in delayed and nondelayed ADHD diagnosis among commercially insured adults in the United States. Poster presented at the 28th Annual US Psychiatric and Mental Health Congress; September 10, 2015. San Diego, CA.
Davis KL, Kaye JA, Iyer S. Response rate and outcomes in crizotinib treated advanced ALK-positive NSCLC patients. Poster presented at the 16th World Congress on Lung Cancer; September 6, 2015. Denver, CO.
Davis KL, Kaye JA, Iyer S. Crizotinib outcomes in ALK-positive advanced NSCLC patients with brain metastases. Presented at the 16th World Conference on Lung Cancer; September 6, 2015. Denver, CO.
Tyczynski JE, Williams S, Gregory N, Garratt M, Tchakov I, Davis KL, Kaye JA, Korsnes JS, Lewis J. Overall survival in platinum-sensitive recurrent ovarian cancer: findings from a multinational medical record review. Poster presented at the 2015 Annual Meeting of the American Society of Clinical Oncology; June 2015. Chicago, IL.
Korsnes JS, Davis KL, Ariely R, Bell C, Mitra D. Health care resource utilization and costs associated with nonfatal major adverse cardiovascular events. J Manag Care Pharm. 2015 Jun;21(6):443-50.
Tyczynski J, Williams S, Gregory N, Garratt M, Tchakov I, Davis KL, Kaye JA, Korsnes J, Lewis J. Real-world treatment patterns for platinum-sensitive recurrent serous ovarian cancer: findings from a multinational medical record review. Poster presented at the 2015 American Society of Clinical Oncology Annual Meeting; June 2015. Chicago, IL. [abstract] J Clin Oncol. 2015 Jun; 33(Suppl):e16548. doi: 10.1200/jco.2015.33.15_suppl.e16548
Davis KL, Lin HM, Zhang S, Kaye JA. Current treatment patterns and survival in relapsed or refractory multiple myeloma: findings from a brief survey of European physicians. Poster presented at the 2015 ISPOR 20th Annual International Meeting; May 2015. Philadelphia, PA.
Goyal RK, Davis KL. Short- and long-term survival associated with laparoscopic versus open colectomy in early-stage colon cancer: findings from a retrospective cohort study. Poster presented at the 2015 ISPOR 20th Annual International Meeting; May 2015. Philadelphia, PA. [abstract] Value Health. 2015 May; 18(3):A194.
Kurosky SK, Davis KL, Krishnarajah G. Effect of receiving combination vaccines on vaccine completion and compliance rates among children aged 24 months in the United States. Presented at the National Foundation for Infectious Disease Annual Meeting; April 13, 2015. Bethesda, MD.
Wang T, Meyers J, Davis K, Madhwani S, Boklage S. Patterns of H. pylori treatment and testing for patients in a commercially insured population. Poster presented at the 2015 AMCP Managed Care & Specialty Pharmacy Annual Meeting; April 1, 2015. San Diego, CA. [abstract] J Manag Care Pharm. 2015 Apr; 21(4-a):S11.
Davis KL, Goyal RK, Able SL, Brown J, Li L, Kaye JA. Real-world treatment patterns, survival, and costs in a US Medicare population with metastatic squamous non–small cell lung cancer. Poster presented at the National Comprehensive Cancer Network (NCCN) 2015 Annual Conference; March 12, 2015. Hollywood, FL.
Davis KL, Goyal RK, Able SL, Brown J, Li L, Kaye JA. Real-world treatment patterns and costs in a US Medicare population with metastatic squamous non-small cell lung cancer. Lung Cancer. 2015 Feb;87(2):176-85. doi: 10.1016/j.lungcan.2014.11.002
Davis KL, Gutierrez B, Zyczynski T, Kaye JA. Real-world treatment patterns in men with castration-resistant prostate cancer receiving docetaxel. JHEOR. 2015 Jan 6;2(2):119-30. doi: 10.36469/9894